toripalimab,nivolumab,durvalumab,pembrolizumab,pemetrexed,cisplatin,gemcitabine,ipilimumab,Vinorelbine,Docetaxel,Carboplatin,Paclitaxel
astrazeneca,bms,merck,junshi biosciences,coherus
['nivo', 'durva', 'toripalimab', 'nsclc', 'pembro', 'sclc']
new kid in the block of neo ct+io in resectable nsclc.after nivo, durva, and toripalimab, pembrolizumab arrives
similar outcome!! 70% receive adj!!pending what patient could deescalate adj treatment? how to test pcr before surgery? is it surgery necessary if pcr?#asco2023 
Medical Oncologist - Thoracic tumors. Personalized treatment approches @EORTC